Filing Details

Accession Number:
0001333493-14-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-16 17:02:46
Reporting Period:
2014-06-12
Filing Date:
2014-06-16
Accepted Time:
2014-06-16 17:02:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333493 Ehealth Inc. EHTH Insurance Agents, Brokers & Service (6411) 770470789
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1366009 Iii L Jack Oliver C/O Ehealth, Inc.
440 East Middlefield Road
Mountain View CA 94043
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-12 4,256 $0.00 38,201 No 4 A Direct
Common Stock Disposition 2014-06-13 3,038 $35.10 35,163 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. This represents an annual award of restricted stock units to our non-employee directors. Each unit represents a contingent right to receive one share of the Issuer's common stock upon vesting. Subject to the Reporting Person's continuous service with the Issuer, the restricted stock units will become 100% vested on the day prior to the Issuer's next annual stockholder meeting approximately one year following the date of grant. The restricted stock units will also become 100% vested if the Issuer is subject to a change in control before the Reporting Person's service terminates.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  3. The price reported in Table I, Column 4 for sales on 6/13/2014 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.85 to $35.69, inclusive. The reporting person undertakes to provide to eHealth, Inc., any security holder of eHealth, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.